ClinicalTrials.gg
RecruitingNCT06603194BECOMEUpdated Sep 19, 2024

Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults

An interventional study of Bovine or Marine Collagen in Skin Laxity, Hair Thinning and Nails, sponsored by Ancient + Brave. Recruiting at 1 site in United Kingdom. Open to female participants aged 35 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Ancient + Brave · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
35 Years to 55 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 11 studies in Alopecia with a site in United Kingdom — 2 open to participants now, 2 under way, 1 of them phase 3. Alopecia · United Kingdom.

Planned enrollment
8th of 11
90 · median 158
Started
2024
the only one that year
No phase
4 of 11
1 open now
Registered
10th of 11
by date
Lead sponsor
1 of 11
Ancient + Brave

Among the 11 studies in Alopecia with a site in United Kingdom, this one is the 8th largest by planned enrollment, is the only one that started in 2024, is one of 4 with no phase, and was the 10th registered.

Alopecia

512 studies on the registry are indexed under Alopecia; 129 are open to participants now.

Browse Alopecia studies →

Open to participants now

2 of the 11 studies in Alopecia with a site in United Kingdom are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 75 Alopecia studies recruiting now, 25 (33%) set no upper age limit and 46 (61%) stop at 75 or younger; 9 take children under 18; 24 take healthy volunteers.

This study: 35 Years to 55 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Alopecia with a site in United Kingdom, or all of them as a file.
02

Study summary

The BECOME Study (Bovine and Marine Collagen Efficacy for Skin, Hair, Nails and Whole Body Health Markers Evaluation) is a randomized controlled trial designed to compare the effects of bovine and marine collagen supplements versus a placebo on skin, hair, nails and whole body health markers. The trial aims to determine the most efficacious collagen source for improving health outcomes and to establish if both types of collagen are equally effective. Participants will be assessed on various health parameters, including skin elasticity, joint health, digestive health, and overall well-being, over a specified period.

03

Conditions studied

  • Skin Laxity
  • Hair Thinning
  • Nails

Browse trials for

Keywords

  • Collagen
  • Skin health
  • Skin density
04

Who can participate

Ages eligible
35 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Females aged 35-55 years. Participants must be comfortable with bovine or marine collagen (non-vegan/vegetarian).

Must provide and be willing to comply with study requirements.

Exclusion criteria

Exclusion Criteria:

Pregnant or breastfeeding women. History of chronic skin conditions (e.g., eczema, psoriasis) that might interfere with study outcomes.

Any active skin infections or severe acne. Currently taking collagen supplements or have taken them within the last 6 months.

Use of medications or topical agents that can affect skin, hair, nails, or gastrointestinal health (e.g., , retinoids).

Excessive alcohol consumption or current smokers. Regular use of sunbeds. Recent cosmetic procedures (e.g., Botox, fillers, chemical peels, laser treatments) on skin, hair, or nails within the last 3 months.

Any condition or situation that, in the opinion of the investigator, may interfere with the participant's ability to comply with the study requirements or give .

Poor adherence to previous study protocols

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
90 participants (estimated)

Study arms

  • Active comparator
    Bovine Collagen

    10g powder format taken daily for duration of the study.

    Dietary Supplement: Bovine or Marine Collagen

  • Active comparator
    Marine Collagen

    10g powder format taken daily for duration of the study.

    Dietary Supplement: Bovine or Marine Collagen

  • Placebo comparator
    Placebo

    Dietary Supplement: Bovine or Marine Collagen

Interventions

  • Dietary supplementBovine or Marine Collagen

    Bovine or Marine Collagen

06

What researchers measure

Primary outcomes

  1. Change in nail strength and growth

    Assessment of nail strength and growth will be assessed by self-perception questionnaire

    Time frame: Baseline, week 6 and week 12

  2. Change in skin elasticity

    Changes in skin elasticity will be measured by a cutometer

    Time frame: Baseline, week 6 and week 12

  3. Change in hair thickness and strength

    Strength and breakage of hair will be assessed by self perception questionnaire

    Time frame: Baseline, week 6 and week 12

  4. Change in skin wrinkles

    Measurement of the reduction in skin wrinkles using Profilometer

    Time frame: Baseline, week 6 and week 12

  5. Change in perceived skin health

    Changes in perceived skin health assessed by self perception questionnaire

    Time frame: Baseline, week 6 and week 12

  6. Change in skin wrinkles by visual assessment

    Change in skin wrinkles will be performed by visual assessment by a dermatologist

    Time frame: Baseline, week 6 and week 12

  7. Changes in skin pigmentation

    Changes in skin pigmentation will be assessed by Chromameter

    Time frame: Baseline, week 6 and week 12

  8. Changes in skin hydration

    Changes in skin hydration will be assessed by a Corneometer

    Time frame: Baseline, week 6 and week 12

Secondary outcomes

  1. Digestive Quality of Life (DQDL) Assessment

    Participants will complete a Digestive Quality of Life (DQDL) Assessment to evaluate the digestive health benefits

    Time frame: Baseline, week 6 and week 12

  2. Subjective Perception Questionnaire

    Subjective Perception Questionnaire (SPQ) for Whole Body Health to capture participants\' self-reported perceptions of their overall health and well-being

    Time frame: Baseline, week 6 and week 12

07

Study locations

1 of 1 sites recruiting
  • Princeton Consumer Research, 8 Richmond Road, Dukes Park
    Chelmsford, Essex CM2 6UA, United Kingdom
    Recruiting
    • Becky Clarke · Contact+441245934050
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2024 (actual). Primary completion is estimated for Nov 2024, 2 months after the start.

Of 61 industry-sponsored interventional studies with no phase under Alopecia, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 20. This study's planned 2 months is below that.

Counting every sponsor, half of 146 studies reached it within 12 months; a quarter within 6 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 28, 2024
First posted
Sep 19, 2024
StartActual
Aug 26, 2024
Primary completionEst.
Nov 25, 2024
CompletionEst.
Dec 20, 2024
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06603194
Lead sponsor
Ancient + Brave
Collaborators
Princeton Consumer Research
Responsible party
Sponsor
First posted
Sep 19, 2024
Start date
Aug 26, 2024
Primary completion
Nov 25, 2024 (estimated)
Completion
Dec 20, 2024 (estimated)
Last update
Sep 19, 2024

Study contacts

Jenna Macciochi, PhD
Contact
jenna@ancientandbrave.earth
+447799090189
Jenna Macciochi, PhD
principal investigator · jenna@ancientandbrave.earth
Becky Clarke
study director · Princeton Consumer Research

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion